Leading Growth Driver in the Renal Insufficiency Market in 2025: Rising Cases Of High Blood Pressure And Diabetes And Their Impact On Kidney Health Driver's Influence

Which drivers are expected to have the greatest impact on the over the renal insufficiency market's growth?
The rising number of high blood pressure and diabetes cases is expected to drive the growth of the renal insufficiency market in the future. High blood pressure and diabetes are linked to factors such as poor diet, physical inactivity, obesity, genetic predisposition, and aging. High blood pressure damages kidney blood vessels through scarring and reduced filtration, while diabetes causes thickening and overwork of kidney vessels due to high blood sugar, both accelerating kidney damage and leading to renal insufficiency. For example, in May 2024, the National Health Service in the UK reported that in December 2023, high blood pressure diagnoses in the South East increased by 71,120 patients, a 5.4% rise compared to December 2022. Additionally, in April 2023, the British Diabetic Association reported that 4.3 million people in the UK were living with diabetes. Therefore, the increasing number of high blood pressure and diabetes cases is contributing to the growth of the renal insufficiency market.

Get Your Renal Insufficiency Market Report Here:
https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report

What is the future CAGR of the renal insufficiency market, and how will it impact industry expansion?
The renal insufficiency market has expanded rapidly, growing from $10.87 billion in 2024 to $12.14 billion in 2025 at a CAGR of 11.7%. This growth is attributed to increasing cases of high blood pressure and diabetes, a growing prevalence of chronic kidney disease (CKD), rising urinary tract obstructions, an aging population, and increasing awareness of kidney health.

The renal insufficiency market is forecasted to expand rapidly, reaching $18.68 billion by 2029 at a CAGR of 11.4%. This growth will be fueled by an increasing incidence of acute kidney injuries (AKI), a higher adoption of home-based treatment solutions, surging healthcare expenditures, and continued research and development investments. Emerging trends include medical technology advancements, personalized medicine integration, innovations in dialysis technology, and the development of novel medications.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp

What are the most significant trends transforming the renal insufficiency market today?
Leading companies in the renal insufficiency market are developing glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to address both renal and cardiovascular complications in patients with diabetes and chronic kidney disease (CKD). GLP-1 RAs help improve glucose control, reduce inflammation, and decrease oxidative stress in the kidneys, slowing the progression of renal insufficiency. For example, in January 2025, Novo Nordisk, a pharmaceutical company based in Denmark, received FDA approval for Ozempic (semaglutide) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes and CKD. This approval underscores the growing importance of GLP-1 RAs in managing both diabetes and renal insufficiency, addressing key unmet needs in patients with progressive CKD.

Which key market segments comprise the renal insufficiency market and drive its revenue growth?
The renal insufficiency market covered in this report is segmented -

1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types
2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes

Subsegments:
1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate
2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)
3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy
4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21271

What regions are at the forefront of renal insufficiency market expansion?
North America was the largest region in the renal insufficiency market in 2024. The regions covered in the renal insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the renal insufficiency market?
Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation, Sorin Group.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp

What Is Covered In The Renal Insufficiency Global Market Report?

•Market Size Forecast: Examine the renal insufficiency market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the renal insufficiency market for a structured understanding.
•Key Players Overview: Analyze major players in the renal insufficiency market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the renal insufficiency market.
•Segment Contributions: Evaluate how different segments drive overall growth in the renal insufficiency market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the renal insufficiency market.
•Industry Challenges: Identify potential risks and obstacles affecting the renal insufficiency market.
•Competitive Landscape: Review strategic developments in the renal insufficiency market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.